As a result, a medical consultation is necessary to determine if semaglutide GLP-1 is suitable for an individuals specific weight management needs
Semaglutide weight loss typically needs to be taken over a period of time making the cost overwhelming for some
Tirzepatide drops and tirzepatide tablet formulations are also in development, with Eli Lilly pursuing an oral tirzepatide that showed promising results in early trials
This structured approach allows the body to adapt, minimizes side effects, and ensures the treatment plan is personalized to the patient's tolerability and response, making the dosing journey as smooth as possible
The BMI criteria for semaglutide treatment for weight management in adults require individuals to have a BMI of 30 or higher (obese), or a BMI of 27 or higher (overweight) accompanied by at least one weight-related condition, such as hypertension, type 2 diabetes, or dyslipidemia